肥胖人群中医证候特征及其与西医表型的关联

注册号:

Registration number:

ChiCTR-OCS-13003640 

最近更新日期:

Date of Last Refreshed on:

2016-03-25 21:25:09 

注册时间:

Date of Registration:

2013-09-02 00:00:00 

注册号状态:

预注册

Registration Status:

Prospective registration

注册题目:

肥胖人群中医证候特征及其与西医表型的关联

Public title:

Relationship between obesity phenotype and Traditional Chinese Medicine ZHENG in obese patients

注册题目简写:

English Acronym:

研究课题的正式科学名称:

肥胖人群中医证候特征及其与西医表型相关性的临床研究

Scientific title:

Clinical research on the relationship between obesity phenotype and Traditional Chinese Medicine ZHENG in obese patients

研究课题代号(代码):

Study subject ID:

在二级注册机构或其它机构的注册号:

The registration number of the Partner Registry or other register:

申请注册联系人:

陶枫 

研究负责人:

陶枫 

Applicant:

Tao Feng 

Study leader:

Tao Feng 

申请注册联系人电话:

Applicant telephone:

+86 21 20256393

研究负责人电话:

Study leader's
telephone:

+86 21 20256393

申请注册联系人传真 :

Applicant Fax:

+86 21 20256393

研究负责人传真:

Study leader's fax:

+86 21 20256393

申请注册联系人电子邮件:

Applicant E-mail:

13818808324@126.com

研究负责人电子邮件:

Study leader's E-mail:

13818808324@126.com

申请单位网址(自愿提供):

Applicant website(voluntary supply):

研究负责人网址(自愿提供):

Study leader's website(voluntary supply):

申请注册联系人通讯地址:

上海市张衡路528号

研究负责人通讯地址:

上海市张衡路528号

Applicant address:

528 ZhangHeng Road, Shanghai

Study leader's address:

528 ZhangHeng Road, Shanghai

申请注册联系人邮政编码:

Applicant postcode:

201203

研究负责人邮政编码:

Study leader's postcode:

201203

申请人所在单位:

上海中医药大学附属曙光医院

Applicant's institution:

ShuGuang Hospital Affiliated with Shanghai University of Traditional Chinese Medicine

研究负责人所在单位:

上海中医药大学附属曙光医院

Affiliation of the Leader:

ShuGuang Hospital Affiliated with Shanghai University of Traditional Chinese Medicine

是否获伦理委员会批准:

Approved by ethic committee:

Yes

伦理委员会批件文号:

Approved No. of ethic committee:

2013-285-54-01

伦理委员会批件附件:

Approved file of Ethical Committee:

批准本研究的伦理委员会名称:

上海中医药大学附属曙光医院伦理委员会

Name of the ethic committee:

IRB of ShuGuang Hospital Affiliated with Shanghai University of Traditional Chinese Medicine

伦理委员会批准日期:

Date of approved by ethic committee:

2013-09-17 00:00:00

伦理委员会联系人:

Contact Name of the ethic committee:

伦理委员会联系地址:

Contact Address of the ethic committee:

伦理委员会联系人电话:

Contact phone of the ethic committee:

伦理委员会联系人邮箱:

Contact email of the ethic committee:

研究实施负责(组长)单位:

上海中医药大学附属曙光医院

Primary sponsor:

ShuGuang Hospital Affiliated with Shanghai University of Traditional Chinese Medicine

研究实施负责(组长)单位地址:

上海市张衡路528号

Primary sponsor's address:

528 ZhangHeng Road, Shanghai

试验主办单位(项目批准或申办者):

Secondary sponsor:

国家:

中国

省(直辖市):

上海

市(区县):

上海

Country:

China

Province:

Shanghai

City:

Shanghai

单位(医院):

上海中医药大学附属曙光医院

具体地址:

上海市张衡路528号

Institution
hospital:

ShuGuang Hospital Affiliated with Shanghai University of Traditional Chinese Medicine

Address:

528 ZhangHeng Road, Shanghai

经费或物资来源:

上海市卫生和计划生育委员会

Source(s) of funding:

Shanghail Board of Health and Family Planning

研究疾病:

肥胖  

Target disease:

Obesity

研究疾病代码:

ICD E66

Target disease code:

ICD E66

研究类型:

观察性研究

Study type:

Observational study

研究所处阶段:

其它 

Study phase:

N/A

研究设计:

横断面 

Study design:

Cross-sectional 

研究目的:

肥胖已成为全球范围的健康问题。随着现代医学对肥胖表型认识的深入,各种肥胖表型在展现优势的同时,也暴露出种种缺陷和不足。探寻新的肥胖表型是近年来的研究热点之一。中医学作为替代医学的杰出代表,对于肥胖有独特的认识。中医“证(候)”能否作为肥胖新的疾病表型?这是本课题的主要研究目的。通过探索肥胖人群的中医证候特征,分析证和肥胖表型的关联,也可以为今后结合两种医学、综合诊治本病提供依据和参考。  

Objectives of Study:

Obesity becomes a global health issue. As anti-obesity research progressing, obesity phenotypes turn out to be a complicated system, showing not only advantages but also defects and deficiencies. To explore new integral phenotype is necessary and urgent. As a prominent representative of alternative medicine, Traditional Chinese Medicine (TCM) has its own concept and recognition of disease, including obesity. ZHENG (also called syndrome) is its specific tool to recognize and to classify patients,which also can guide treatment. Our hypothesis is that ZHENG can be used as a new obesity phenotype, relating to existing phenotypes. In our study, we intend to explore ZHENG characteristics among obese patients and to associate ZHENG (syndrome element, tongue parameter)to obesity phenotypes (body composition, energy expenditure, etc). Our results are supposed to be potential for anti-obesity treatment integrated by Western Medicine and TCM in the future.

药物成份或治疗方案详述:

无 

Description for medicine or protocol of treatment in detail:

none 

纳入标准:

Inclusion criteria

排除标准:

①对中医有反感;②曾经接受中医知识培训;③孕妇;④合并严重肝肾疾病;⑤严重抑郁或者精神疾病未得到控制,无法回答问卷;⑥继发性肥胖(内分泌疾病,基因异常等);⑦无法完成西医表型的相关检测。

Exclusion criteria:

1. rejecting Traditional Chinese Medicine;
2. knowledged by Traditional Chinese Medicine;
3. pregnant women;
4. complicated with severe liver or kidney disease;
5. suffering depression or mental illness out of control, unable to finish the questionnaire;
6. secondary obesity (endocrine disease, genetic, etc.);
7. unable to complete some measurements.

研究实施时间:

Study execute time:

From 2013-09-01 00:00:00 To 2014-12-31 00:00:00  

征募观察对象时间:

Recruiting time:

From 2013-10-04 00:00:00 To 2014-11-30 00:00:00

干预措施:

Interventions:

组别:

未分组

样本量:

300

Group:

none

Sample size:

干预措施:

没有干预措施

干预措施代码:

Intervention:

Nil

Intervention code:

研究实施地点:

Countries of recruitment and research settings:

国家:

中国

省(直辖市):

上海 

市(区县):

上海 

Country:

China

Province:

Shanghai

City:

Shanghai

单位(医院):

上海中医药大学附属曙光医院 

单位级别:

三级甲等医院 

Institution
hospital:

ShuGuang Hospital Affiliated with Shanghai University of Traditional Chinese Medicine

Level of the institution:

Tertiary A hospital

测量指标:

Outcomes:

指标中文名:

证素

指标类型:

主要指标

Outcome:

Syndrome element

Type:

Primary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

体重

指标类型:

主要指标

Outcome:

body weight

Type:

Primary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

体重指数

指标类型:

主要指标

Outcome:

body mass index

Type:

Primary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

体质组成

指标类型:

主要指标

Outcome:

body composition

Type:

Primary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

体质分布

指标类型:

主要指标

Outcome:

body distributio

Type:

Primary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

基础代谢率

指标类型:

次要指标

Outcome:

resting energy expenditure

Type:

Secondary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

名: 血脂

指标类型:

次要指标

Outcome:

lipidemia

Type:

Secondary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

糖代谢

指标类型:

次要指标

Outcome:

glycemia

Type:

Secondary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

体重史

指标类型:

次要指标

Outcome:

weight history

Type:

Secondary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

胰岛素

指标类型:

次要指标

Outcome:

insulin

Type:

Secondary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

生长激素

指标类型:

次要指标

Outcome:

ghrelin

Type:

Secondary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

瘦素

指标类型:

次要指标

Outcome:

leptin

Type:

Secondary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

脂联素

指标类型:

次要指标

Outcome:

adiponectin

Type:

Secondary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

白介素6

指标类型:

次要指标

Outcome:

intereukin-6

Type:

Secondary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

抵抗素

指标类型:

次要指标

Outcome:

resistin

Type:

Secondary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

舌象参数

指标类型:

次要指标

Outcome:

tongue index

Type:

Secondary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

采集人体标本:

Collecting sample(s)
from participants:

标本中文名:

血液

组织:

静脉

Sample Name:

blood

Tissue:

vein

人体标本去向

使用后销毁  

说明

Fate of sample:

Destruction after use  

Note:

征募研究对象情况:

Recruiting status:

结束

/Completed

年龄范围:

Participant age:

最小 Min age 18 years
最大 Max age 65 years

性别:

男女均可

Gender:

Both

随机方法(请说明由何人用什么方法产生随机序列):

未随机

Randomization Procedure (please state who generates the random number sequence and by what method):

none

是否公开试验完成后的统计结果:

Calculated Results after the Study Completed public access:

公开/Public

盲法:

Blinding:

试验完成后的统计结果(上传文件):

Calculated Results after
the Study Completed(upload file):

是否共享原始数据:

IPD sharing

共享原始数据的方式(说明:请填入公开原始数据日期和方式,如采用网络平台,需填该网络平台名称和网址):

上海中医药大学附属曙光医院

The way of sharing IPD”(include metadata and protocol, If use web-based public database, please provide the url):

ShuGuang Hospital Affiliated with Shanghai University of Traditional Chinese Medicine

数据采集和管理(说明:数据采集和管理由两部分组成,一为病例记录表(Case Record Form, CRF),二为电子采集和管理系统(Electronic Data Capture, EDC),如ResMan即为一种基于互联网的EDC:

上海中医药大学附属曙光医院

Data collection and Management (A standard data collection and management system include a CRF and an electronic data capture:

ShuGuang Hospital Affiliated with Shanghai University of Traditional Chinese Medicine

数据与安全监察委员会:

Data and Safety Monitoring Committee:

注册人:

Name of Registration:

 2013-09-28 00:00:00